Potassium channel activators based on the benzopyran substructure: Synthesis and activity of the C-8 substituent

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 8, 2003, Pages 1663-1668

  Thompson, Rona ^a   Doggrell, Sheila ^b   Hoberg, John O ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDRO 6 CYANO 3 HYDROXY 8 METHOXY 4 PYROLIDINE 2,2 DIMETHYL 2H 1 BENZOPYRAN; 3,4 DIHYDRO 6 CYANO 4 (1,2 DIHYDRO 2 OXO 1 PYRIDYL) 3 HYDROXY 8 METHOXY 2,2 DIMETHYL 2H 1 BENZOPYRAN; 6 CYANO 8 METHOXY 4 (1,2 DIHYDRO 2 OXO 1 PYRIDYL) 2,2 DIMETHYL 2H 1 BENZOPYRAN; 6 CYANO 8 METHOXY 4 (PIPERIDIN 2 ONE) 2,2 DIMETHYL 2H 1 BENZOPYRAN; 6 CYANO 8 METHOXY 4 (PYRROLIDIN 2 ONE) 2,2 DIMETHYL 2H 1 BENZOPYRAN; BENZOPYRAN DERIVATIVE; CROMAKALIM; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG; VANILLIN;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EPOXIDATION; NONHUMAN; PORTAL VEIN; RAT; RING OPENING; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 12244280866     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00058-0     Document Type: Article

References (31)

1. Nicolaou K.C., Pfefferkorn J.A., Barluenga S., Mitchell H.J., Roecker A.J., Cao G.-Q. J. Am. Chem. Soc. 122:2000;9968.
2. (a) Jankun J., Selman S.H., Swiercz R., Skrzypczak-Jankun E. Nature. 1997;387 (b) Covington A.D. Chem. Soc. Rev. 1997;111 (c) Van Rensburg H., van Heerden P.S., Bezuidenhoudt B.C.B., Ferreira D. Tetrahedron Lett. 38:1997;3089 (d) Rochfort S.J., Metzger R., Hobbs L., Capon R.J. Aust. J. Chem. 49:1996;1217.
3. (a) Jankun J., Selman S.H., Swiercz R., Skrzypczak-Jankun E. Nature. 1997;387 (b) Covington A.D. Chem. Soc. Rev. 1997;111 (c) Van Rensburg H., van Heerden P.S., Bezuidenhoudt B.C.B., Ferreira D. Tetrahedron Lett. 38:1997;3089 (d) Rochfort S.J., Metzger R., Hobbs L., Capon R.J. Aust. J. Chem. 49:1996;1217.
4. (a) Jankun J., Selman S.H., Swiercz R., Skrzypczak-Jankun E. Nature. 1997;387 (b) Covington A.D. Chem. Soc. Rev. 1997;111 (c) Van Rensburg H., van Heerden P.S., Bezuidenhoudt B.C.B., Ferreira D. Tetrahedron Lett. 38:1997;3089 (d) Rochfort S.J., Metzger R., Hobbs L., Capon R.J. Aust. J. Chem. 49:1996;1217.
5. (a) Jankun J., Selman S.H., Swiercz R., Skrzypczak-Jankun E. Nature. 1997;387 (b) Covington A.D. Chem. Soc. Rev. 1997;111 (c) Van Rensburg H., van Heerden P.S., Bezuidenhoudt B.C.B., Ferreira D. Tetrahedron Lett. 38:1997;3089 (d) Rochfort S.J., Metzger R., Hobbs L., Capon R.J. Aust. J. Chem. 49:1996;1217.
6. Hiessbock R., Wolf C., Richter E., Hitzler M., Chiba P., Kratzel M., Ecker G. J. Med. Chem. 42:1999;1921.
7. Pinto I.L., Buckle D.R., Readshaw S.A., Smith D.G. Bioorg. Med. Chem. Lett. 3:1993;1743.
8. Ashwood V.A., Buckingham R.E., Cassidy F., Evans J.M., Faruk E.A., Hamilton T.C., Nash D.J., Stemp G., Willcocks K. J. Med. Chem. 29:1986;2194.
9. (a) Bergmann R., Gericke R. J. Med. Chem. 33:1990;492 (b) Puddu P.E., Garlid K.D., Monti F., Iwashiro K., Picard S., Dawodu A.A., Criniti A., Ruvolo G., Campa P.P. Cardiovasc. Drug Rev. 18:2000;25.
10. (a) Bergmann R., Gericke R. J. Med. Chem. 33:1990;492 (b) Puddu P.E., Garlid K.D., Monti F., Iwashiro K., Picard S., Dawodu A.A., Criniti A., Ruvolo G., Campa P.P. Cardiovasc. Drug Rev. 18:2000;25.
11. (a) Arch, J. R. S. In Potassium Channels Their Modulators; Evans, J. M., Ed.; Taylor & Francis: London, UK, 1996; p 275. (b) Ando T., Kume H., Urata T., Takagi K. Clin. Exp. Allergy. 27:1997;705 (c) Arch J.R.S., Bowring N.E., Buckle D.R. Pulm. Pharmacol. 7:1994;121 (d) Jan L.Y., Jan Y.N. Nature. 345:1990;672 (e) Hoshi T., Zagotta W.N. Curr. Opin. Neurobiol. 3:1993;283.
12. (a) Arch, J. R. S. In Potassium Channels Their Modulators; Evans, J. M., Ed.; Taylor & Francis: London, UK, 1996; p 275. (b) Ando T., Kume H., Urata T., Takagi K. Clin. Exp. Allergy. 27:1997;705 (c) Arch J.R.S., Bowring N.E., Buckle D.R. Pulm. Pharmacol. 7:1994;121 (d) Jan L.Y., Jan Y.N. Nature. 345:1990;672 (e) Hoshi T., Zagotta W.N. Curr. Opin. Neurobiol. 3:1993;283.
13. (a) Arch, J. R. S. In Potassium Channels Their Modulators; Evans, J. M., Ed.; Taylor & Francis: London, UK, 1996; p 275. (b) Ando T., Kume H., Urata T., Takagi K. Clin. Exp. Allergy. 27:1997;705 (c) Arch J.R.S., Bowring N.E., Buckle D.R. Pulm. Pharmacol. 7:1994;121 (d) Jan L.Y., Jan Y.N. Nature. 345:1990;672 (e) Hoshi T., Zagotta W.N. Curr. Opin. Neurobiol. 3:1993;283.
14. (a) Arch, J. R. S. In Potassium Channels Their Modulators; Evans, J. M., Ed.; Taylor & Francis: London, UK, 1996; p 275. (b) Ando T., Kume H., Urata T., Takagi K. Clin. Exp. Allergy. 27:1997;705 (c) Arch J.R.S., Bowring N.E., Buckle D.R. Pulm. Pharmacol. 7:1994;121 (d) Jan L.Y., Jan Y.N. Nature. 345:1990;672 (e) Hoshi T., Zagotta W.N. Curr. Opin. Neurobiol. 3:1993;283.
15. (a) Arch, J. R. S. In Potassium Channels Their Modulators; Evans, J. M., Ed.; Taylor & Francis: London, UK, 1996; p 275. (b) Ando T., Kume H., Urata T., Takagi K. Clin. Exp. Allergy. 27:1997;705 (c) Arch J.R.S., Bowring N.E., Buckle D.R. Pulm. Pharmacol. 7:1994;121 (d) Jan L.Y., Jan Y.N. Nature. 345:1990;672 (e) Hoshi T., Zagotta W.N. Curr. Opin. Neurobiol. 3:1993;283.
16. Noma A. Nature. 305:1983;147.
17. Ammala C., Moorhouse A., Ashcroft F.M. J. Physiol. 494:1996;709.
18. Edwards G., Weston A.H. Trends Pharmacol. Sci. 11:1990;417.
19. (a) Chiu H.-I., Lin Y.-C., Cheng C.-Y., Tsai M.-C., Yu H.-C. Bioorg. Med. Chem. 9:2001;383 (b) Mannhold R., Cruciani G., Weber H., Lemoine H., Derix A., Weichel C., Clementi M. J. Med. Chem. 42:1999;981 (c) Balckburn T.P., Buckingham R.E., Chan W.N., Evans J.M., Hadley M.S., Thompson M., Upton N., Stean T.O., Stemp G. Bioorg. Med. Chem. Lett. 5:1995;1163 (d) Evans J.M., Hamilton T.C., Longman S.D., Stemp G. Potassium Channels and Their Modulators. From Synthesis to Clinical Experience. 1996;Taylor & Francis, London.
20. (a) Chiu H.-I., Lin Y.-C., Cheng C.-Y., Tsai M.-C., Yu H.-C. Bioorg. Med. Chem. 9:2001;383 (b) Mannhold R., Cruciani G., Weber H., Lemoine H., Derix A., Weichel C., Clementi M. J. Med. Chem. 42:1999;981 (c) Balckburn T.P., Buckingham R.E., Chan W.N., Evans J.M., Hadley M.S., Thompson M., Upton N., Stean T.O., Stemp G. Bioorg. Med. Chem. Lett. 5:1995;1163 (d) Evans J.M., Hamilton T.C., Longman S.D., Stemp G. Potassium Channels and Their Modulators. From Synthesis to Clinical Experience. 1996;Taylor & Francis, London.
21. (a) Chiu H.-I., Lin Y.-C., Cheng C.-Y., Tsai M.-C., Yu H.-C. Bioorg. Med. Chem. 9:2001;383 (b) Mannhold R., Cruciani G., Weber H., Lemoine H., Derix A., Weichel C., Clementi M. J. Med. Chem. 42:1999;981 (c) Balckburn T.P., Buckingham R.E., Chan W.N., Evans J.M., Hadley M.S., Thompson M., Upton N., Stean T.O., Stemp G. Bioorg. Med. Chem. Lett. 5:1995;1163 (d) Evans J.M., Hamilton T.C., Longman S.D., Stemp G. Potassium Channels and Their Modulators. From Synthesis to Clinical Experience. 1996;Taylor & Francis, London.
22. (a) Chiu H.-I., Lin Y.-C., Cheng C.-Y., Tsai M.-C., Yu H.-C. Bioorg. Med. Chem. 9:2001;383 (b) Mannhold R., Cruciani G., Weber H., Lemoine H., Derix A., Weichel C., Clementi M. J. Med. Chem. 42:1999;981 (c) Balckburn T.P., Buckingham R.E., Chan W.N., Evans J.M., Hadley M.S., Thompson M., Upton N., Stean T.O., Stemp G. Bioorg. Med. Chem. Lett. 5:1995;1163 (d) Evans J.M., Hamilton T.C., Longman S.D., Stemp G. Potassium Channels and Their Modulators. From Synthesis to Clinical Experience. 1996;Taylor & Francis, London.
23. Evans J.M., Fake C.S., Hamilton T.C., Poyser R.H., Showell G.A. J. Med. Chem. 27:1984;1127.
24. (a) Bjorsvik H.-R. Org. Process Res. Dev. 3:1999;330. and references therein (b) Anastas, P. T.; Williamson, T. C., Eds. Green Chemistry: Frontiers in Benign Chemical Syntheses and Processes, Oxford Press, Oxford, 1998.
25. (a) Bjorsvik H.-R. Org. Process Res. Dev. 3:1999;330. and references therein (b) Anastas, P. T.; Williamson, T. C., Eds. Green Chemistry: Frontiers in Benign Chemical Syntheses and Processes, Oxford Press, Oxford, 1998.
26. Although 4-hydroxy-3-methoxybenzonitrile is commercially available, it is more economical to convert vanillin using the convenient procedure developed by Olah: Olah G.A., Keumi T. Synthesis. 1979;112, see Experimental.
27. Chang S., Lee N.H., Jacobsen E.N. J. Org. Chem. 58:1993;6939.
28. (a) Wang W.-D., Espenson J.H. J. Am. Chem. Soc. 120:1998;11335 (b) Adolfsson H., Coperet C., Chiang J.P., Yudin A.K. J. Org. Chem. 65:2000;8651.
29. (a) Wang W.-D., Espenson J.H. J. Am. Chem. Soc. 120:1998;11335 (b) Adolfsson H., Coperet C., Chiang J.P., Yudin A.K. J. Org. Chem. 65:2000;8651.
30. Evans J.M., Fake C.S., Hamilton T.C., Poyser R.H., Watts E.A. J. Med. Chem. 26:1983;1582.
31. Doggrell S.A., Liang L.C. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;126.